Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
about
Assessment of cardiac function in children with congenital adrenal hyperplasia: a case control study in Cameroon.Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyNeonatal mass screening for 21-hydroxylase deficiency.Carotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal HyperplasiaHypertension in children with congenital adrenal hyperplasia.Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.Left ventricular dysfunction and subclinical atherosclerosis in children with classic congenital adrenal hyperplasia: a single-center study from upper Egypt.Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.Care provision in congenital adrenal hyperplasia - all doom and gloom or light at the end of the tunnel?Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia.Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
P2860
Q33587493-9FE3CE8C-E033-4B66-80BE-8E8A7A3EDE71Q35916502-F4433DAF-C8EC-4BD2-9386-B50BF4A4F3F9Q36535856-36B95989-E589-4D45-A6EE-86202B62D16AQ36896732-156B44B6-3B01-4A22-B1D0-106BCB208A0BQ38814973-7227AFA4-6F43-44EE-A775-A07729B8309AQ38931092-F24BA853-EF3B-4E53-9709-00751D648A31Q38948900-2669A2D8-048F-4D88-9220-777F717DF22EQ39247750-BE9416E7-493F-47FE-BA64-83E4B7CD975DQ40335044-E31E6C50-7150-41BA-97FC-B518D5E37E18Q40838929-E7833002-1796-4145-8AA6-284922F41749Q44914129-C4C3B24C-D07E-4BF3-B38B-2A3ED92B81A8Q51317526-0642CD0E-74E1-4894-BC06-92D2C6A7666DQ54354901-09A67144-3679-4126-9E82-08F601BF74FF
P2860
Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@ast
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@en
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@nl
type
label
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@ast
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@en
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@nl
prefLabel
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@ast
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@en
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@nl
P2093
P2860
P921
P356
P1476
Cardiovascular risk factors in ...... to 21-hydroxylase deficiency.
@en
P2093
Anbezhil Subbarayan
Catherine J Peters
Mehul T Dattani
Peter C Hindmarsh
P2860
P304
P356
10.1111/CEN.12265
P577
2013-07-08T00:00:00Z